Delivery Order 75N93023D00015-75N93023F00002
Award Date 6/20/23
Potential Completion Date 6/19/30
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,696,523.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer, for NIAID's Preclinical Development Support program. The contract has a period of performance through December 31, 2026 and is a cost-plus-fixed-fee type. ABL, a leading contract research and manufacturing organization, provides a range of preclinical and clinical development services to support...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The contract, valued at $6,633.90, does not have a set-aside designation. ABL is a contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. Under this contract, ABL will provide a range of...
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $1,826,332.06, is for the provision of preclinical development support services related to the NIAID's infectious disease research and product development...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL). The contract, with a ceiling value of $186,316.03, is for the manufacture and characterization of vaccines and other biologics. ABL, a foreign-owned, for-profit organization that specializes in biopharmaceutical research and development, is a leading contract research and manufacturing...
- This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer. The $2,152,834.00 contract is for preclinical development support services, including biologics manufacturing, testing, storage, shipping, and quality assurance. ABL has been awarded over $35...
- Advanced Bioscience Laboratories, Inc. (ABL) was awarded a delivery order contract valued at $2.1M by the National Institute of Allergy and Infectious Diseases (NIAID) on June 10, 2017, under the Essential Core Activities III program for Preclinical Development Support. The contract, which operates on a cost-plus-fixed-fee basis with no set-aside designation, is scheduled for completion by June 8, 2029, and will be performed in Potomac, Maryland. As a leading contract research and...
- This is a task order awarded under the Preclinical Services for Biopharmaceutical Product Development indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The $110,115.92 task order was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit organization that specializes in manufacturing and testing biologics such as gene therapies, vaccines, and immunotherapies....
- This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL) for $784,847.21. The contract is for the manufacture and characterization of vaccines. ABL is a foreign-owned, for-profit manufacturer of goods that specializes in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The...
- The federal contract award is to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit organization that specializes in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The contract, with a ceiling value of $2,745,187.57, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract is a Delivery Order with a...
- This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The contract, valued at $213,045,738.00, is for preclinical development services to support infectious disease research and product development initiatives. The contract does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants,...